FAILED
首站-论文投稿智能助手
典型文献
Promoting axon regeneration in the central nervous system by increasing PI3-kinase signaling
文献摘要:
Much research has focused on the PI3-kinase and PTEN signaling pathway with the aim to stimulate repair of the injured central nervous system.Axons in the central nervous system fail to regenerate,meaning that injuries or diseases that cause loss of axonal connectivity have life-changing consequences.In 2008,genetic deletion of PTEN was identified as a means of stimulating robust regeneration in the optic nerve.PTEN is a phosphatase that opposes the actions of PI3-kinase,a family of enzymes that function to generate the membrane phospholipid PIP3 from PIP2(phosphatidylinositol(3,4,5)-trisphosphate from phosphatidylinositol(4,5)-bisphosphate).Deletion of PTEN therefore allows elevated signaling downstream of PI3-kinase,and was initially demonstrated to promote axon regeneration by signaling through mTOR.More recently,additional mechanisms have been identified that contribute to the neuron-intrinsic control of regenerative ability.This review describes neuronal signaling pathways downstream of PI3-kinase and PIP3,and considers them in relation to both developmental and regenerative axon growth.We briefly discuss the key neuron-intrinsic mechanisms that govern regenerative ability,and describe how these are affected by signaling through PI3-kinase.We highlight the recent finding of a developmental decline in the generation of PIP3 as a key reason for regenerative failure,and summarize the studies that target an increase in signaling downstream of PI3-kinase to facilitate regeneration in the adult central nervous system.Finally,we discuss obstacles that remain to be overcome in order to generate a robust strategy for repairing the injured central nervous system through manipulation of PI3-kinase signaling.
文献关键词:
作者姓名:
Bart Nieuwenhuis;Richard Eva
作者机构:
John van Geest Center for Brain Repair,Department of Clinical Neurosciences,University of Cambridge,Cambridge,UK
引用格式:
[1]Bart Nieuwenhuis;Richard Eva-.Promoting axon regeneration in the central nervous system by increasing PI3-kinase signaling)[J].中国神经再生研究(英文版),2022(06):1172-1182
A类:
Axons,opposes
B类:
Promoting,regeneration,central,nervous,system,by,increasing,PI3,kinase,signaling,Much,research,has,focused,PTEN,aim,stimulate,injured,regenerate,meaning,that,injuries,diseases,cause,loss,axonal,connectivity,have,life,changing,consequences,In,genetic,deletion,was,identified,means,stimulating,robust,optic,nerve,phosphatase,actions,family,enzymes,function,membrane,phospholipid,PIP3,from,PIP2,phosphatidylinositol,trisphosphate,bisphosphate,Deletion,therefore,allows,elevated,downstream,initially,demonstrated,promote,through,mTOR,More,recently,additional,mechanisms,been,contribute,intrinsic,control,regenerative,ability,This,review,describes,neuronal,pathways,considers,them,relation,both,developmental,growth,We,briefly,discuss,key,govern,how,these,are,affected,highlight,finding,decline,reason,failure,summarize,studies,target,increase,facilitate,adult,Finally,we,obstacles,remain,overcome,order,strategy,repairing,manipulation
AB值:
0.498432
相似文献
mTORC1 induces plasma membrane depolarization and promotes preosteoblast senescence by regulating the sodium channel Scn1a
Ajuan Chen;Jian Jin;Shasha Cheng;Zezheng Liu;Cheng Yang;Qingjing Chen;Wenquan Liang;Kai Li;Dawei Kang;Zhicong Ouyang;Chenfeng Yao;Xiaochun Bai;Qingchu Li;Dadi Jin;Bin Huang-Academy of Orthopedics,Guangdong Province,Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases,Department of Spine Surgery,The Third Affiliated Hospital of Southern Medical University,Guangzhou,China;Department of Spine Surgery,Nanfang Hospital,Southern Medical University,Guangzhou,China;Department of Clinical Laboratory,The Third Affiliated Hospital of Southern Medical University,Guangzhou,China;Department of Cell Biology,School of Basic Medical Science,Southern Medical University,Guangzhou,China
Molecular insights into ligand recognition and G protein coupling of the neuromodulatory orphan receptor GPR139
Yali Zhou;Henrik Daver;Boris Trapkov;Lijie Wu;Meng Wu;Kasper Harps?e;Patrick R.Gentry;Kaiwen Liu;Marina Larionova;Junlin Liu;Na Chen;Hans Br(a)uner-Osborne;David E.Gloriam;Tian Hua;Zhi-Jie Liu-iHuman Institute,ShanghaiTech University,Shanghai,China;School of Life Science and Technology,ShanghaiTech University,Shanghai,China;University of Chinese Academy of Sciences,Beijing,China;CAS Center for Excellence in Molecular Cell Science,Shanghai Institute of Biochemistry and Cell Biology,Chinese Academy of Sciences,Shanghai,China;Department of Drug Design and Pharmacology,University of Copenhagen,Universitetsparken 2,Copenhagen,Denmark;Photobiology laboratory,Institute of Biophysics SB RAS,Federal Research Center "Krasnoyarsk Science Center SB RAS",Akademgorodok 50/50,Krasnoyarsk,Russia
EGFR signaling promotes nuclear translocation of plasma membrane protein TSPAN8 to enhance tumor progression via STAT3-mediated transcription
Xiaoqing Lu;Liwei An;Guangjian FanTi;Lijuan Zang;Weiyi Huang;Junjian Li;Jun Liu;Weiyu Ge;Yuwei Huang;Jingxuan Xu;Shaoqian Du;Yuan Cao;Tianhao Zhou;Huijing Yin;Li Yu;Shi Jiao;Hongxia Wang-State Key Laboratory of Oncogenes and Related Genes,Department of Oncology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;Department of Breast Surgery,Shanxi Cancer Hospital,Chinese Academy of Medical Sciences,Taiyuan,Shanxi,China;Department of Medical Ultrasound,Shanghai Tenth People's Hospital,Tongji University Cancer Center,School of Medicine,Tongji University,Shanghai,China;Precision Research Center for Refractory Diseases,Institute for Clinical Research,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;Department of Pathology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;State Key Laboratory of Membrane Biology,Tsinghua-Peking University Joint Center for Life Sciences,School of Life Science,Tsinghua University,Beijing,China;State Key Laboratory of Genetic Engineering,School of Life Sciences,Fudan University,Shanghai,China
Inhibiting Hv1 channel in peripheral sensory neurons attenuates chronic inflammatory pain and opioid side effects
Qiansen Zhang;Yimin Ren;Yiqing Mo;Peipei Guo;Ping Liao;Yuncheng Luo;Jie Mu;Zhuo Chen;Yang Zhang;Ya Li;Linghui Yang;Daqing Liao;Jie Fu;Juwen Shen;Wei Huang;Xuewen Xu;Yanyan Guo;Lianghe Mei;Yunxia Zuo;Jin Liu;Huaiyu Yang;Ruotian Jiang-Shanghai Key Laboratory of Regulatory Biology,Institute of Biomedical Sciences,School of Life Sciences,East China Normal University,Shanghai,China;Laboratory of Anesthesia and Critical Care Medicine,National-Local Joint Engineering Research Center of Translational Medicine of Anesthesiology,West China Hospital,Sichuan University,Chengdu,Sichuan,China;Department of Anesthesiology,the Affiliated Hospital of Guizhou Medical University,Guiyang,Guizhou,China;Department of Integrated Traditional Chinese and Western Medicine,Sichuan Provincial Pancreatitis Centre and West China-Liverpool Biomedical Research Centre,West China Hospital,Sichuan University,Chengdu,Sichuan,China;Department of Burn and Plastic Surgery,West China Hospital of Sichuan University,Chengdu,Sichuan,China;Suzhou Institute of Drug Innovation,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Suzhou,Jiangsu,China
A novel PI3K inhibitor XH30 suppresses orthotopic glioblastoma and brain metastasis in mice models
Ming Ji;Dongjie Wang;Songwen Lin;Chunyang Wang;Ling Li;Zhihui Zhang;Jing Jin;Deyu Wu;Yi Dong;Heng Xu;Duo Lu;Xiaoguang Chen-State Key Laboratory of Bioactive Substances and Functions of Natural Medicines,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-κB/IL-6/STAT3 and JNK/PTX3 pathways
Wan Li;Hongqing Cai;Liwen Ren;Yihui Yang;Hong Yang;Jinyi Liu;Sha Li;Yizhi Zhang;Xiangjin Zheng;Wei Tan;Guanhua Du;Jinhua Wang-The State Key Laboratory of Bioactive Substance and Function of Natural Medicines,Beijing 100050,China;Key Laboratory of Drug Target Research and Drug Screen,Institute of Materia Medica,Chinese Academy of Medical Science and Peking Union Medical College,Beijing 100050,China;Department of Neurosurgery,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;State Key Laboratory of Molecular Oncology,Center for Cancer Precision Medicine,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;School of Pharmacy,Xinjiang Medical University,Urumqi 830011,China;Xinjiang Institute of Materia Medica,Urumqi 830004,China
Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway
Yi-kuan Wu;Zheng-nan Ren;Sheng-long Zhu;Yun-zhou Wu;Gang Wang;Hao Zhang;Wei Chen;Zhao He;Xian-long Ye;Qi-xiao Zhai-State Key Laboratory of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Medicine,Jiangnan University,Wuxi 214122,China;College of Life Science,Northeast Agricultural University,Harbin 150038,China;National Engineering Research Center for Functional Food,Jiangnan University,Wuxi 214122,China;Shandong Key Laboratory of Endocrinology and Lipid Metabolism,Jinan 250021,China;School of Medicine,Shandong University,Jinan 250012,China;Ganjiang Chinese Medicine Innovation Center,Nanchang 330000,China
IMM-H007 attenuates isoprenaline-induced cardiac fibrosis through targeting TGFβ1 signaling pathway
Shuai-xing Wang;Ye-nan Feng;Shan Feng;Ji-min Wu;Mi Zhang;Wen-li Xu;You-yi Zhang;Hai-bo Zhu;Han Xiao;Er-dan Dong-Department of Cardiology and Institute of Vascular Medicine,Peking University Third Hospital,NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides,Key Laboratory of Molecular Cardiovascular Science,Ministry of Education,Beijing Key Laboratory of Cardiovascular Receptors Research,Beijing 100191,China;State Key Laboratory for Bioactive Substances and Functions of Natural Medicines,Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。